13th International Clinical Cancer Genomics Conference: Accelerating Technology Enabled Precision Oncology

Chicago, IL US
April 23, 2026 to April 25, 2026
Advancements in biomarker and genomic technologies continue to transform cancer care, enabling personalized risk assessment, targeted screening, and precision treatments. As we enter a new era of precision medicine, comprehensive understanding of cancer genomics and the immune microenvironment allows clinicians to identify individuals at the highest risk for lethal, yet treatable, malignancies—thus optimizing surveillance, prevention, and patient outcomes. Landmark achievements, such as the identification of BRCA1 mutation carriers (enabling cancer prevention strategies and PARP inhibitor therapy) and the management of Lynch Syndrome (leading to curative immunotherapeutic approaches for rectal cancer), illustrate the profound impact of genomics on the continuum of care.
 
We are convening a 3-day in-person conference with 20 world-renowned faculty experts in cancer genomics and over 500 participants with the goal of establishing a Learning Group Network of up to 1000 people at the 13th International Clinical Cancer Genomics Conference—Accelerating Technology Enabled Precision Oncology, where stakeholders will share state-of-the-art science, latest technologies—including Artificial Intelligence—real-world case studies, curated pedigrees, and actionable case summaries. This forum is designed to equip healthcare professionals with practical tools and evidence-based guidelines for managing high-risk patients and their families, with a strong emphasis on technologies that broaden access to biomarker-informed, patient centric precision oncology across the continuum of care from prevention to survivorship.

Target Audience

This activity has been designed for physicians, physician assistants, advanced nurse practitioners, genetic counselors, oncology nurses, pharmacists, and other healthcare professionals currently involved in providing cancer genetics risk assessment services or initiating such services in their health care system. Special efforts will be made to meet the needs of clinicians practicing in non-academic centers and geographically and/or socioeconomically underserved communities.

Learning Objectives

After participating in the activity, participants should be better able to:

  • Collaborate with patient advocates to bring patient voices to round table discussions and platform presentations;
  • Review advances in genetics, genomics, and next generation Omics technologies transforming precision oncology;
  • Evaluate controversies in risk prediction and genomic testing for management decisions, including integration of liquid biopsies into risk adapted treatment;
  • Discuss emerging concepts in digital pathology, and integration of Artificial Intelligence in developing Multi-Omics-based biomarkers;
  • Develop innovative mentoring platforms for trainees and introduce early Career Researchers to International Genomics focused Consortia such as ENIGMA, CIMBA, Africa Oncogenetics Network, Asia Oncogenetics Network and America Oncogenetics Network;
  • Debate ethical implications and opportunities presented by AI tools in health care.
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
Kristen Shephard
CME Coordinator Contact Email: 
[email protected]
AttachmentSize
PDF icon 13th International Clinical Cancer Genomics Conference Prospectus.pdf6.7 MB

You may also be interested in

3rd Annual University of Chicago Stroke Symposium
3rd Annual University of Chicago Stroke Symposium
David Rubenstein Forum | Chicago, IL
 
This activity will provide the latest updates in stroke care from regional and international experts and will feature a session highlighting a patient panel sharing personal experiences with stroke care.
29th University of Chicago Comprehensive Cancer Center Developmental Therapeutics Symposium
David Rubenstein Forum | Chicago, IL
 
The goals of this activity are for participants to examine synthesized data from completed studies, discuss the novel investigational agents available in ongoing clinical trials, and describe the rationale for and the results of studies that include novel agents to treat patients with advanced cancer.
3rd Annual University of Chicago Practice Updates in Hematology and Oncology
3rd Annual University of Chicago Practice Updates in Hematology and Oncology
Hilton Chicago/Oak Brook Hills Resort & Conference Center | Oak Brook, IL
 
This activity meets a significant regional need by offering Midwest clinicians a cost-effective, accessible alternative to national meetings, delivering high-quality oncology education.
Summary
Available credit: 
  • 22.25 ABIM Medical Knowledge
  • 22.25 AMA PRA Category 1 Credit™
  • 21.25 Genetic Counseling CEU
  • 22.25 Nursing Contact Hours
  • 22.25 Participation
Event starts: 
04/23/2026 - 7:00am
Event ends: 
04/25/2026 - 5:00pm
Activity opens: 
03/11/2026
Activity expires: 
05/29/2026
Add to calendar: 
THURSDAY, APRIL 23, 2026
TimeSession
Pre-conference: Hereditary Hematologic Cancers Primer and Case-Based Workshop
Location: Renaissance Ballroom		 
8:00am–8:10amWelcome, Introductions, Overview — Kathleen Blazer, Director & Jane Churpek, MD, MS, Program Chair
8:10am–8:20amBasics of Hematology Relevant to Germline Genetic Testing — Jane Churpek, MD, MS
8:20am–8:35amIndications and Guidelines for Germline Testing in Patients with Hematologic Malignancies/Disorders — Christopher Reilly, MD
8:35am–8:50amNew Horizons in Genetic Test and Sample Type Selection for Hereditary Hematologic Malignancy Syndromes — Lauren Banaszak, MD
8:50am–9:05amUpdates on Variant Curation and Interpretation for Hematologic Malignancy Predisposition Disorders — Lucy Godley, MD
9:05am–9:35amImplementing a Hereditary Hematology Program — Raymond Kim, MD and Brittany Stewart, MS, CGC
9:35am–9:50amQ&A / Participant and Panel Discussion
9:50am–10:00amBreak
10:00am-10:55am

Putting It All Together: Team-Based Learning (TBL) Part 1: Breakout Sessions

 

Faculty Panel: Jane Churpek, MD, MS, Christopher Reilly, MD, Lauren Banaszak, MD, Lucy Godley, MD, PhD; Raymond Kim, MD, PhD and Brittany Stewart, MS, CGC, PhD

Moderators: Emma Adams, MS, CGC, Alex Capasso, MS, CGC, Lauren Gima, MS,CGC, Bita Nehoray, MS, GCG Elise Sobotka, MS, MPH, CGC, Kaila Wilson, MS, CGC. Elyssa Zukin, MS, CGC, Suzie Shehayeb, MS, CGC, Sandra Dreike, MS, CGC, Ilana Solomon, ScM, CGC, Christina Rybak, MS, CGC, Feighanne Hathaway, MS, CGC, Rachelle Manookian MS, CGC

10:55am-11:05amBreak
11:05am–12:05pm

Putting It All Together: Team-Based Learning (TBL) Part 2: Case Review and Discussion

 

 Faculty Panel: Jane Churpek, MD, MS, Christopher Reilly, MD,
Lauren Banaszak, MD, Lucy Godley, MD, PhD, Raymond Kim, MD, PhD,
and Brittany Stewart, MS, CGC

 

Moderators: Emma Adams, MS, CGC, Alex Capasso, MS, CGC, Lauren Gima, MS,CGC,
Bita Nehoray, MS, GCG Elise Sobotka, MS, MPH, CGC, Kaila Wilson, MS, CGC.
Elyssa Zukin, MS, CGC, Suzie Shehayeb, MS, CGC, Sandra Dreike, MS, CGC,
Ilana Solomon, ScM, CGC, Christina Rybak, MS, CGC, Feighanne Hathaway, MS, CGC,
Rachelle Manookian, MS, CGC 

12:05pm–12:10pmPre-Conference Summary / Closing Remarks
12:10pm–2:00pmBreak
1:00pm–2:00pmEarly Career Mentorship Sessions
2:00pm-2:05pmOpening Remarks- Olufumilayo Olopade, MD
2:00pm–2:20pmHistorical Perspective on the Evolution of Cancer Genetics — Cancer Center Director: Kunle Odunsi, MD, PhD
Session 1: Genetic Testing is Getting More Complicated! Specimens and Technologies
Moderators: Sulin Wu, MD, PhD & Feighanne Hathaway, MS, CGC
Location: Grand Ballroom		 
2:20pm–2:50pmLeveraging Artificial Intelligence for Automated Interpretation of Cancer Gene Variants — Jeremy Segal, MD
2:50pm–3:20pmKeynote Address I: Solving Difficult Variants with New Specimens and Technologies: Long-read Sequencing, Paired Tumor, RNA Testing — Tom Walsh, PhD
3:20pm–3:50pmMutation Signatures as Clues to the Underlying Gene — Kara Maxwell, MD, PhD
3:50pm–4:20pmComplexities of Risk Estimation, Test Interpretation and Cancer Risk Management — Tuya Pal, MD
4:20pm–5:00pmGreat Debate: Should VUS be clinically reported? — Heather Hampel, MS and Colin Pritchard, MD
5:00pm–5:15pm

Question & Answer Panel Discussion

Panelists: Jeremy Segal, MD, Tom Walsh, PhD, Kara Maxwell, MD, PhD, Tuya Pal, MD,
Heather Hampel, MS, CGC, Colin Pritchard, MD, PhD

5:15pm–7:00pmWelcome Reception & Poster Session (Location: Renaissance Ballroom)
FRIDAY, APRIL 24, 2026
TimeSession
7:00am–7:50amNon-CME Breakfast Product Theater: Precision Medicine: Biomarker Testing Challenges, Opportunities, and the MDT
7:00am-7:50Early Career Mentorship Sessions       Location: Renaissance
Session 2: 30+ years after BRCA1 and BRCA2 Discoveries – Lessons Learned about Menopause and Survivorship
Moderators: Lorraine Canham, MD & Rodrigo Guindalini, MD
Location: Grand Ballroom		 
8:00am–8:10amWelcome and Announcements
8:10am–8:35amTaking Care of Women Across the Lifespan – Birth Control and Fertility Issues — Nicole Edison, MD
8:35am–8:55amUpdate on Risk Reducing Surgeries — Nora Jaskowiak, MD
8:55am–9:15amHormonal Therapy & Transgender Care — Iris Romero, MD
9:15am–9:45amKeynote Address II: Hormone Replacement Therapy in HBOC Patients and Long-Term Outcomes — Joane Kotsopoulos, PhD
9:45am–10:00amQuestion & Answer Panel Discussion
Panelists: Nicole Edison, MD; Nora Jaskowiak, MD; Iris Romero, MD; Joane Kotsopoulos, PhD
10:00am–11:00amVoices of Patient Advocates
Moderators: Lisa Madlensky, PhD, CGC and Olufunmilayo Olopade, MD
Panelists: Kathy Baker, Anna Woodard, PhD, Ricki Fairley, & Joelle Kaufman
11:00am–11:15amBreak
Session 3: Transforming Hematology/Oncology Care through Genetics
Moderators: Daniel Arber, MD & Stacy Gray, MD
Location: Grand Ballroom		 
11;15am-11;20amHarvey Golomb Memorial Introduction- Olufunmilayo Olopade, MD
11:20am–12:00pmDr. Harvey Golomb Distinguished Lectureship in Cancer Genetics — Ashok Venkitaraman, MBBS, PhD
12:00am–12:20pmUpdate on Cancer Genetics Education Across the Globe — Charles Balch, MD
12:20pm–12:40pmYoung Onset Lung Cancer — Marina Garassino, MD
12:40pm–1:00pm

Session 3 Q&A Panel

Panelists: Ashok Ventkitaraman, MD, PhD, Charles Balch, MD,
Marina Garassino, MD, & Olufunmilayo Olopade, MD
1:00pm–2:00pmLunch
1:10pm–1:50pmNon-CME Product Theater: (Location: Hemingway)
Session 4: Case Presentations with Interprofessional Panel Discussions
Moderators: Jane Churpek, MD, MS & Bita Nehoray, MS, CGC
Location: Grand Ballroom		 
2:00pm–3:30pmCase Presentations with Interprofessional Panel Discussions Focused on Incorporating Germline and Somatic Genetic Data into Patient Risk Management and Precision Cancer Treatment
Panel: Colin Pritchard, MD, PhD; Kara Maxwell, MD, PhD; Heather Hampel, MS, CGC; Pamela Ganschow, MD; Elias Obeid, MD, MPH; Michael Hall, MD
Session 5: 30+ years after BRCA1 and BRCA2 Discoveries – Lessons learned from Management of Multiple Cancers
Moderators: Emma Sass and Elias Obeid, MD, MPH
Location: Grand Ballroom		 
3:30pm–4:00pmKeynote Address III: Breast Cancer Information Core — 30+ years of Curation to Advance HBOC Cure — Lawrence Brody, PhD
4:00pm–4:25pmPrecision Oncology to Impact Men’s Health — Ari Rosenberg, MD
4:25pm–4:45pmParp Inhibitors in Hematology — Michael Drazer, MD, PhD
4:45pm–5:00pmQuestion & Answer Panel Discussion
Panelists: Lawrence Brody, PhD; Ari Rosenberg, MD; Michael Drazer, MD, PhD
5:00pm–5:45pmBreakout Sessions – Late Breaking Topics

Room Topic: Innovations in High Risk Screening — Kirti Kulkarni, MD & Milica Medved, PhD, DAPMB
Moderators: Greg Karczmar, PhD and Cara Essling, APP

Room Topic: High Risk Breast & Prostate Cancer — Elias Obeid, MD, MPH & Joanne Jeter, MD
Moderator: Iris Romero, MD and Sulin Wu, MD, PhD

Room Topic: Breast Cancer Prevention Studies: Challenges & Opportunities — Adetunji Toriola, MD, PhD & Jeffrey Weitzel, MD
Moderator: Rodrigo Guindalini, MD and Wenji Guo, MD, PhD
5:45pmAdjourn
7:00pm-10:00pmDisco through the Decades: CCGCoP Silver Anniversary Gala: Renaissance Ballroom
SATURDAY, APRIL 25, 2026
TimeSession
7:00am–7:50amEarly Career Mentorship Sessions- Location: Hemingway
Session 6: AI Integration into Oncology Care
Moderator: Anna Woodard, PhD and Subomi Omoleye, MD
Location: Grand Ballroom		 
8:10am–8:35amHarnessing AI for Risk Stratification and Precision Treatment in Breast Cancer — Frederick Howard, MD
8:35am–9:00amPopulation Risk Stratification using SNPs and Mammographic AI — Jeffrey Tice, PhD
9:00am–9:25amAI in Mammography Screening: Are We There Yet? — Randy Miles, MD
9:25am–9:55amKeynote Address V: Multi-Omics Approach to Breast Cancer Risk Prediction — Adam Yala, PhD
9:55am–10:15amQuestion & Answer Panel Discussion
Panelists: Frederick Howard, MD; Jeffrey Tice, PhD; Randy Miles, MD; Adam Yala, PhD
10:15am-10:45amBreak
10:15am–10:45am

Early Career Mentorship Session-            Location: Hemingway

Session 7: Accelerating Progress in Early Detection & Cancer Interception
Moderators: Jan-Marie McEvilly, RN, MS, OCN & Pamela Ganschow, MD
Location: Grand Ballroom		 
10:45am–11:05amContralateral Breast Cancer Risk in Women with PALB2-Associated Breast Cancer — Kelly Metcalfe, RN, PhD
11:05am–11:30amKeynote Address VI: Communicating Health Risks to Women: Lessons from the United Kingdom — Itunu Johnson-Sogbetun, MBBS
11:30am–11:50amGLP-1–Therapies: Emerging Evidence from Weight Loss to Disease Management — Silvana Pannain, MD
11:50am–12:30pmQuestion & Answer Panel Discussion
12:30pm–1:45pmLunch Break
12:45pm-1:45pm

Lunch and Learn Mentoring Session with Patient Advocates

Location: Hemingway

Session 8: Will Immuno Oncology Accelerate Cures In High Risk Populations: Technology, Testing, Treatment
Moderators: Christine Drogan, MS, CGC & Lorraine Canham, MD
Location: Grand Ballroom		 
1:45pm–2:05pmVaccines for Women's Cancer: Lessons Learned — Nita Lee, MD, MPH
2:05pm–2:40pmKeynote Address VII: Immuno Oncology Update for Lynch Syndrome Cancers: Successes and Failures — Michael Hall, MD
2:40pm–3:00pm

Rapid Fire Sessions
Moderators: Lisa Madlensky, PhD, CGC and Michael Drazer, MD, PhD

 Missed Opportunities for Early Detection: Over Half of Lung Cancers at UCMC Fall Outside USPSTF Screening Eligibility
Sulin Wu, MD, PhD


The WISDOM 2.0 Study: Initial Trends in Pathogenic Variants Among Women 30-39 in a Nationwide Risk-Based Breast Cancer Screening Trial
Hillary Hsu, BS


Inherited Risk for Prostate Cancer (PCa): Following the Natural History of Men with Increased Genetic Risk using Multiparametric MRI (mpMRI)
Anna Couvillon, MSN, APRN, FNP-C


Cancer Genetic Risk Assessment (CGRA) Certification:
Outcomes from the First Six Years
Kristie Bobolis, MD
3:00pm–3:15pmBreak
Session 9: Expanding Infrastructure to Implement Biomarker Informed Clinical Trials and Precision Oncology at Scale
Moderators: Jeffrey Weitzel, MD and Michael Mullane, MD
Location: Grand Ballroom		 
3:15pm–3:35pmImplementation Science to Expand Navigational Services for Precision Oncology — Ted Skolarus, MD
3:35pm–3:55pmVHL Center of Excellence: Implications of germline findings in Renal Cell Carcinoma — Jonathan Trujillo, MD, PhD
3:55pm–4:15pmDeveloping a Center of Excellence for Women's Cancers in Ontario Canada for Impact across the Globe — Steven Narod, MD
4:15pm–5:00pmWrap Up: The Future of Cancer Interception Studies — Judy Garber, MD, MPH and Olufunmilayo Olopade, MD

The agenda is subject to change.

InterContinental Chicago Magnificent Mile by IHG
505 North Michigan Avenue
Chicago, IL 60611
United States
WANT TO KNOW MORE?
Learn more about the program by visiting the conference website! For questions, contact Kristen at Meeting Achievements via e-mail.
 
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office via e-mail at [email protected].
 
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
CONFERENCE LEADERSHIP
Olufunmilayo Falusi Olopade, MBBS, FACP
Walter L. Palmer Distinguished Service Professor
Director, Center for Clinical Cancer Genetics
Departments of Medicine and Human Genetics
University of Chicago
 
Kathleen Blazer, EdD, MS, CGC
Professor, Department of Medical Oncology and Therapeutics Research
Director, Cancer Genomics Education Program
City of Hope National Medical Center
 
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 22.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Genetic Counselor Credit
The National Society of Genetic Counselors (NSGC) has authorized University of Chicago Pritzker School of Medicine to offer up to 2.125 CEUs or 21.25 Category 1 contact hours for the activity 13th International Clinical Cancer Genomics Conference. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.

Nursing Credit
University of Chicago Medicine is accredited as a provider of continuing nursing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Participants who successfully complete the entire activity and complete an evaluation form will earn 22.25 contact hours.
 
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 22.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Other Health Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.

Please note: The credit claiming process will close 30 days after the activity ends. Requests to claim credit after 30 days may incur additional fees.

For more information on opportunities for exhibits and sponsorships, please contact:

Annie Smith, CMP

Phone: 219.465.1115 Ext. 114

Email:  [email protected]

 

Registration: Click the button below for complete registration information and to register.


REGISTRATION

 
Claiming Credit: After the conference, create or log into your UChicago CME account and enter the access code to unlock the credit claiming process.
Please note: The credit claiming process will close 30 days after the activity ends. Requests to claim credit after 30 days may incur additional fees.
Please login or create an account to proceed.